KJ
Kory James Wentworth
DELAYED 1 MONTH
Chief Financial Officer
Entrada Therapeutics, Inc.
Filings
3
Companies
1
Latest
Mar 9, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
58
Entrada Therapeutics, Inc.
Kory James Wentworth
Chief Financial Officer
Sale
$148.2K
11,388 sh
Mar 11 8:34 PM
Mar 10, 2026
58
Entrada Therapeutics, Inc.
Kory James Wentworth
Chief Financial Officer
Sale
$66.2K
5,089 sh
Mar 11 8:34 PM
Mar 9, 2026
53
Entrada Therapeutics, Inc.
Kory James Wentworth
Chief Financial Officer
Sale
$97.9K
7,988 sh
Mar 6 9:36 PM
Mar 4, 2026